| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. | Director | Stock options | 269,040 | 27 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000149315224025677-hamilton-john-f-2024-06-27 | Aridis Pharmaceuticals, Inc. | 27 Jun 2024 | 1 | $0 | 4 | Director | 28 Jun 2024, 20:36 |
| /report/000149315223033065-hamilton-john-f-2023-09-18 | Aridis Pharmaceuticals, Inc. | 18 Sep 2023 | 1 | $0 | 4 | Director | 19 Sep 2023, 16:05 |
| /report/000149315223021483-hamilton-john-f-2023-05-04 | Aridis Pharmaceuticals, Inc. | 04 May 2023 | 3 | $0 | 4 | Director | 15 Jun 2023, 17:14 |
| /report/000149315222034677-hamilton-john-f-2022-12-05 | Aridis Pharmaceuticals, Inc. | 05 Dec 2022 | 1 | $0 | 4 | Director | 07 Dec 2022, 07:58 |
| /report/000110465921123251-hamilton-john-f-2021-10-04 | Aridis Pharmaceuticals, Inc. | 04 Oct 2021 | 1 | $0 | 4 | Director | 05 Oct 2021, 18:26 |
| /report/000110465921096534-hamilton-john-f-2021-07-27 | Aridis Pharmaceuticals, Inc. | 27 Jul 2021 | 1 | +$9,740 | 4 | Director | 27 Jul 2021, 21:37 |